YVETTE KIMBLE: Open Payments
NPI 1598201048 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 20 payments from 13 companies in 2025. Trend: 2023 $507 · 2024 $1,334 · 2025 $2,121
Food & beverage: $2,121
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $385 |
| Madrigal Pharmaceuticals | 2 | $275 |
| ABBVIE INC. | 2 | $213 |
| COLOPLAST CORP | 2 | $170 |
| Insulet Corporation | 1 | $169 |
| Boston Scientific Corporation | 2 | $145 |
| ACADIA Pharmaceuticals Inc | 2 | $119 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $111 |
| Inspire Medical Systems, Inc. | 1 | $111 |
Products named: REZDIFFRA, EVENITY, OMNIPOD, APOLLO ESG System, LINZESS, NUPLAZID, TRYVIO, Epclusa.
Industry payments across IL — which companies pay providers there.
